Skip to the page

Data / Drug companies / Kenvue Brands LLC

Kenvue Brands LLC: 143 products in the FDA NDC directory, labeler code 50580

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Kenvue Brands LLC (labeler code 50580) lists 143 products in the FDA National Drug Code Directory, covering 24 finished drugs by generic name. By type: 137 over the counter drugs, 6 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on October 1, 2026.

The request: Watch Kenvue Brands LLC (FDA labeler code 50580): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
50580
Products in commercial distribution
143
Packages
363
Finished drugs by generic name
24
Prescription products
0
Over the counter products
137
Flagged as original packager
131 of 131 products that carry the flag
Started marketing in the last 12 months
10
Products with a marketing end date set
1
Earliest marketing start
August 19, 1984
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs9767.8%
New drug applications (NDA)2517.5%
Generic drugs (ANDA)1510.5%
Drugs for further processing64.2%

Products by type

TypeProductsShare
Over the counter drugs13795.8%
Drugs for further processing64.2%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet, film coated4128.7%
Suspension2114.7%
Kit1611.2%
Solution139.1%
Capsule, liquid filled96.3%
Tablet, chewable96.3%
Tablet, coated64.2%
Tablet, film coated, extended release64.2%
Tablet42.8%
Liquid42.8%
Spray32.1%
Powder21.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Cetirizine50580-003Tablet, film coatedDrugs for further processingOctober 1, 2026
Extra Strength Tylenol Cold Plus Flu Multi-Symptom Day Night50580-585KitOver the counter monograph drugsSeptember 1, 2026
Extra Strength TYLENOL Cold plus Flu Multi Symptom Day50580-586Tablet, film coatedOver the counter monograph drugsJune 18, 2026
Extra Strength Tylenol Cold plus Flu Multi-Symptom Daytime50580-213LiquidOver the counter monograph drugsJune 12, 2026
Sudafed Sinus Congestion plus Cold Severe Day and Night50580-660KitOver the counter monograph drugsJune 10, 2026
Sudafed Sinus Congestion Plus Cold Severe Day50580-659Tablet, film coatedOver the counter monograph drugsJune 10, 2026
Extra Strength Tylenol Cold plus Flu Multi-Symptom Nighttime50580-212LiquidOver the counter monograph drugsJune 1, 2026
Infants TYLENOL50580-154SuspensionOver the counter monograph drugsApril 13, 2026
Tylenol Cold Plus Flu Plus Chest Congestion50580-584Tablet, film coatedOver the counter monograph drugsMarch 6, 2026
TYLENOL Extra Strength50580-187SuspensionOver the counter monograph drugsNovember 28, 2025
Diphenhydramine hydrochloride50580-002Tablet, film coatedDrugs for further processingNovember 1, 2025
TYLENOL Extra Strength50580-469Capsule, liquid filledOver the counter monograph drugsOctober 27, 2025
TYLENOL Extra Strength50580-108Tablet, film coatedOver the counter monograph drugsOctober 13, 2025
Diphenhydramine hydrochloride50580-001Tablet, film coatedDrugs for further processingOctober 1, 2025
Childrens TYLENOL50580-517Tablet, chewableOver the counter monograph drugsSeptember 1, 2025
TYLENOL Extra Strength50580-491Tablet, film coatedOver the counter monograph drugsAugust 30, 2025
TYLENOL Regular Strength50580-475Tablet, film coatedOver the counter monograph drugsAugust 30, 2025
TYLENOL Cold Plus Flu Multi-Symptom Liquid Gels Day Plus Night50580-141KitOver the counter monograph drugsJune 30, 2025
SUDAFED OM Sinus Severe No Drip Nasal Mist with Cooling Menthol50580-368SprayOver the counter monograph drugsJune 16, 2025
SUDAFED OM Sinus Severe No Drip Nasal Mist50580-364SprayOver the counter monograph drugsJune 16, 2025
Extra Strength TYLENOL Severe Cough Plus Sore Throat Day50580-140LiquidOver the counter monograph drugsJune 6, 2025
ZYRTEC Hives50580-116Tablet, film coatedNew drug applications (NDA)June 2, 2025
Benadryl Allergy Extra Strength Liqui-Gels50580-322Capsule, liquid filledOver the counter monograph drugsMay 15, 2025
Childrens tylenol50580-139SuspensionOver the counter monograph drugsApril 28, 2025
Zyrtec hives50580-128SolutionNew drug applications (NDA)April 2, 2025

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.